Guidance
Update information
August 2016: Added a footnote to recommendations 1.4.11 and 1.4.12 covering the new advice from the Medicines and Healthcare products Regulatory Agency (MHRA) about safety concerns related to ivabradine (June 2014 and December 2014) and nicorandil (January 2016).
Minor changes since publication
December 2012: The licensing information for nicorandil was updated.
ISBN: 978-1-4731-2047-1